CoChat

A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus

Open access
Birru, Rahel L., Liang, Hai-Wei, Farooq, Fouzia, Bedi, Megha, Feghali, Maisa, Haggerty, Catherine L., Mendez, Dara D., Catov, Janet M., Ng, Carla A., Adibi, Jennifer J. · 2021 · Environmental Health
Cited by 70

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Abstract

Per- and polyfluoroalkyl substances (PFAS) have been found to be associated with gestational diabetes mellitus (GDM) development, a maternal health disorder in pregnancy with negative effects that can extend beyond pregnancy. Studies that report on this association are difficult to summarize due to weak associations and wide confidence intervals. One way to advance this field is to sharpen the biologic theory on a causal pathway behind this association, and to measure it directly by way of molecular biomarkers. The aim of this review is to summarize the literature that supports a novel pathway between PFAS exposure and GDM development. Epidemiological studies demonstrate a clear association of biomarkers of thyroid hormones and glucose metabolism with GDM development. We report biologic plausibility and epidemiologic evidence that PFAS dysregulation of maternal thyroid hormones and thyrotropin (TSH) may disrupt glucose homeostasis, increasing the risk of GDM. Overall, epidemiological studies demonstrate that PFAS were positively associated with TSH and negatively with triiodothyronine (T3) and thyroxine (T4). PFAS were generally positively associated with glucose and insulin levels in pregnancy. We propose dysregulation of thyroid function and glucose metabolism may be a critical and missing component in the accurate estimation of PFAS on the risk of GDM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12940-021-00740-z

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 35 references

Research works printed but not linked: 94

  1. Faithfull NS, Weers JG. Perfluorocarbon compounds. Vox Sang. 1998;74(Suppl 2):243–8. https://doi.org/10.1111/j.1423-0410.1998.tb05426.x. · doi:10.1111/j.1423-0410.1998.tb05426.x
  2. Bjerregaard-Olesen C, Bossi R, Liew Z, Long M, Bech BH, Olsen J, Henriksen TB, Berg V, Nøst TH, Zhang JJJIjoh, et al. Maternal serum concentrations of perfluoroalkyl acids in five international birth cohorts. Int J Hyg Environ Health. 2017;220(2):86–93. · DOI
  3. Tian Y, Zhou Y, Miao M, Wang Z, Yuan W, Liu X, et al. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China. Environ Int. 2018;119:165–73. https://doi.org/10.1016/j.envint.2018.06.015. · DOI · Paper page
  4. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50. https://doi.org/10.1016/j.diabres.2017.03.024. · DOI · Paper page
  5. Parsons J, Sparrow K, Ismail K, Hunt K, Rogers H, Forbes A. Experiences of gestational diabetes and gestational diabetes care: a focus group and interview study. BMC Pregnancy Childbirth. 2018;18(1):25. https://doi.org/10.1186/s12884-018-1657-9. · DOI · Paper page
  6. Johnson J. Diabetes control in thyroid disease. Diabetes Spectrum. 2006;19(3):148–53. https://doi.org/10.2337/diaspect.19.3.148. · DOI
  7. Cicatiello AG, Di Girolamo D, Dentice M. Metabolic effects of the intracellular regulation of thyroid hormone: old players, new concepts. Front Endocrinol (Lausanne). 2018;9:474. https://doi.org/10.3389/fendo.2018.00474. · DOI · Paper page
  8. Park EA, Song S, Vinson C, Roesler WJ. Role of CCAAT enhancer-binding protein beta in the thyroid hormone and cAMP induction of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem. 1999;274(1):211–7. https://doi.org/10.1074/jbc.274.1.211. · DOI · Paper page
  9. Brenta G. Why can insulin resistance be a natural consequence of thyroid dysfunction? J Thyroid Res. 2011;2011:152850. · DOI · Paper page
  10. Hage M, Zantout MS, Azar ST. Thyroid disorders and diabetes mellitus. J Thyroid Res. 2011;2011:439463. · DOI · Paper page
  11. Walsh JP. Managing thyroid disease in general practice. Med J Aust. 2016;205(4):179–84. https://doi.org/10.5694/mja16.00545. · DOI · Paper page
  12. Hwang GB, Yoon JS, Park KJ, Lee HS, Hwang JS. Prevalence of autoimmune thyroiditis in patients with type 1 diabetes: a long-term follow-up study. Ann Pediatr Endocrinol Metab. 2018;23(1):33–7. https://doi.org/10.6065/apem.2018.23.1.33. · DOI
  13. Merrill SJ, Mu Y. Thyroid autoimmunity as a window to autoimmunity: an explanation for sex differences in the prevalence of thyroid autoimmunity. J Theor Biol. 2015;375:95–100. https://doi.org/10.1016/j.jtbi.2014.12.015. · DOI
  14. Brent GA. Environmental exposures and autoimmune thyroid disease. Thyroid. 2010;20(7):755–61. https://doi.org/10.1089/thy.2010.1636. · DOI · Paper page
  15. Tal R, Taylor HS, Burney RO, Mooney SB, Giudice LC. Endocrinology of Pregnancy. In: Endotext Edited by Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P et al. South Dartmouth; MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278962/.
  16. Korevaar TI, de Rijke YB, Chaker L, Medici M, Jaddoe VW, Steegers EA, et al. Stimulation of thyroid function by human chorionic gonadotropin during pregnancy: a risk factor for thyroid disease and a mechanism for known risk factors. Thyroid. 2017;27(3):440–50. https://doi.org/10.1089/thy.2016.0527. · DOI
  17. Korevaar TI, Steegers EA, de Rijke YB, Visser WE, Jaddoe VW, Visser TJ, et al. Placental Angiogenic factors are associated with maternal thyroid function and modify hCG-mediated FT4 stimulation. J Clin Endocrinol Metab. 2015;100(10):E1328–34. https://doi.org/10.1210/jc.2015-2553. · DOI
  18. Vissenberg R, Manders VD, Mastenbroek S, Fliers E, Afink GB, Ris-Stalpers C, et al. Pathophysiological aspects of thyroid hormone disorders/thyroid peroxidase autoantibodies and reproduction. Hum Reprod Update. 2015;21(3):378–87. https://doi.org/10.1093/humupd/dmv004. · DOI · Paper page
  19. Moog NK, Entringer S, Heim C, Wadhwa PD, Kathmann N, Buss C. Influence of maternal thyroid hormones during gestation on fetal brain development. Neuroscience. 2017;342:68–100. https://doi.org/10.1016/j.neuroscience.2015.09.070. · DOI · Paper page
  20. James SR, Franklyn JA, Kilby MD. Placental transport of thyroid hormone. Best Pract Res Clin Endocrinol Metab. 2007;21(2):253–64. https://doi.org/10.1016/j.beem.2007.03.001. · DOI
  21. Chan SY, Vasilopoulou E, Kilby MD. The role of the placenta in thyroid hormone delivery to the fetus. Nat Clin Pract Endocrinol Metab. 2009;5(1):45–54. https://doi.org/10.1038/ncpendmet1026. · DOI · Paper page
  22. Maraka S, Ospina NM, O'Keeffe DT, Espinosa De Ycaza AE, Gionfriddo MR, Erwin PJ, et al. Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid. 2016;26(4):580–90. https://doi.org/10.1089/thy.2015.0418. · DOI · Paper page
  23. Morreale de Escobar G, Obregon MJ, Escobar del Rey F. Role of thyroid hormone during early brain development. Eur J Endocrinol. 2004;151(Suppl 3):U25–37. · DOI · Paper page
  24. Forhead AJ, Fowden AL. Thyroid hormones in fetal growth and prepartum maturation. J Endocrinol. 2014;221(3):R87–r103. https://doi.org/10.1530/JOE-14-0025. · DOI · Paper page
  25. Liu Y, Guo F, Maraka S, Zhang Y, Zhang C, Korevaar T, et al. Associations between human chorionic gonadotropin, maternal free Thyroxine, and gestational Diabetes mellitus. Thyroid. 2021. https://doi.org/10.1089/thy.2020.0920. · DOI
  26. Donovan BM, Nidey NL, Jasper EA, Robinson JG, Bao W, Saftlas AF, et al. First trimester prenatal screening biomarkers and gestational diabetes mellitus: a systematic review and meta-analysis. Plos One. 2018;13(7):e0201319. https://doi.org/10.1371/journal.pone.0201319. · DOI · Paper page
  27. Leng J, Li W, Wang L, Zhang S, Liu H, Li W, et al. Higher thyroid-stimulating hormone levels in the first trimester are associated with gestational diabetes in a Chinese population. Diabet Med. 2019;36(12):1679–85. https://doi.org/10.1111/dme.14106. · DOI
  28. Gong LL, Liu H, Liu LH. Relationship between hypothyroidism and the incidence of gestational diabetes: a meta-analysis. Taiwan J Obstet Gynecol. 2016;55(2):171–5. https://doi.org/10.1016/j.tjog.2016.02.004. · DOI · Paper page
  29. Aggarawal N, Suri V, Singla R, Chopra S, Sikka P, Shah VN, et al. Pregnancy outcome in hyperthyroidism: a case control study. Gynecol Obstet Investig. 2014;77(2):94–9. https://doi.org/10.1159/000357615. · DOI
  30. Yang Y, Li Q, Wang Q, Ma X. Thyroid antibodies and gestational diabetes mellitus: a meta-analysis. Fertil Steril. 2015;104(3):665–71 e663. https://doi.org/10.1016/j.fertnstert.2015.06.003. · DOI
  31. Jia M, Wu Y, Lin B, Shi Y, Zhang Q, Lin Y, et al. Meta-analysis of the association between maternal subclinical hypothyroidism and gestational diabetes mellitus. Int J Gynaecol Obstet. 2019;144(3):239–47. https://doi.org/10.1002/ijgo.12751. · DOI · Paper page
  32. Huang K, Xu Y, Yan S, Li T, Xu Y, Zhu P, et al. Isolated effect of maternal thyroid-stimulating hormone, free thyroxine and antithyroid peroxidase antibodies in early pregnancy on gestational diabetes mellitus: a birth cohort study in China. Endocr J. 2019;66(3):223–31. https://doi.org/10.1507/endocrj.EJ18-0340. · DOI · Paper page
  33. American Diabetes A. 14. Management of Diabetes in pregnancy: standards of medical Care in Diabetes-2020. Diabetes Care. 2020;43(Suppl 1):S183–92. https://doi.org/10.2337/dc20-S014. · DOI · Paper page
  34. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462–70. https://doi.org/10.2337/diacare.22.9.1462. · DOI · Paper page
  35. McNeil AR, Stanford PE. Reporting thyroid function tests in pregnancy. Clin Biochem Rev. 2015;36(4):109–26.
  36. Spencer CA. Assay of thyroid hormones and related substances. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, Dungan K, Grossman A, Hershman JM, Kaltsas G, Koch C, Kopp P, et al., editors. Endotext. South Dartmouth: MDText.com, Inc.; 2000.
  37. Soldin OP, Soldin SJ. Thyroid hormone testing by tandem mass spectrometry. Clin Biochem. 2011;44(1):89–94. https://doi.org/10.1016/j.clinbiochem.2010.07.020. · DOI · Paper page
  38. Liu X, Zhang L, Chen L, Li J, Wang Y, Wang J, et al. Structure-based investigation on the association between perfluoroalkyl acids exposure and both gestational diabetes mellitus and glucose homeostasis in pregnant women. Environ Int. 2019;127:85–93. https://doi.org/10.1016/j.envint.2019.03.035. · DOI · Paper page
  39. Matilla-Santander N, Valvi D, Lopez-Espinosa MJ, Manzano-Salgado CB, Ballester F, Ibarluzea J, et al. Exposure to Perfluoroalkyl substances and metabolic outcomes in pregnant women: evidence from the Spanish INMA birth cohorts. Environ Health Perspect. 2017;125(11):117004. https://doi.org/10.1289/EHP1062. · DOI · Paper page
  40. Preston EV, Rifas-Shiman SL, Hivert MF, Zota AR, Sagiv SK, Calafat AM, Oken E, James-Todd T. Associations of Per- and Polyfluoroalkyl Substances (PFAS) With Glucose Tolerance During Pregnancy in Project Viva. J Clin Endocrinol Metab. 2020;105(8):e2864–e2876. · DOI · Paper page
  41. Rahman ML, Zhang C, Smarr MM, Lee S, Honda M, Kannan K, et al. Persistent organic pollutants and gestational diabetes: a multi-center prospective cohort study of healthy US women. Environ Int. 2019;124:249–58. https://doi.org/10.1016/j.envint.2019.01.027. · DOI · Paper page
  42. Shapiro GD, Dodds L, Arbuckle TE, Ashley-Martin J, Ettinger AS, Fisher M, et al. Exposure to organophosphorus and organochlorine pesticides, perfluoroalkyl substances, and polychlorinated biphenyls in pregnancy and the association with impaired glucose tolerance and gestational diabetes mellitus: the MIREC study. Environ Res. 2016;147:71–81. https://doi.org/10.1016/j.envres.2016.01.040. · DOI · Paper page
  43. Wang H, Yang J, Du H, Xu L, Liu S, Yi J, et al. Perfluoroalkyl substances, glucose homeostasis, and gestational diabetes mellitus in Chinese pregnant women: a repeat measurement-based prospective study. Environ Int. 2018;114:12–20. https://doi.org/10.1016/j.envint.2018.01.027. · DOI
  44. Xu H, Zhou Q, Zhang J, Chen X, Zhao H, Lu H, et al. Exposure to elevated per- and polyfluoroalkyl substances in early pregnancy is related to increased risk of gestational diabetes mellitus: a nested case-control study in Shanghai, China. Environ Int. 2020;143:105952. https://doi.org/10.1016/j.envint.2020.105952. · DOI · Paper page
  45. Wang Y, Zhang L, Teng Y, Zhang J, Yang L, Li J, et al. Association of serum levels of perfluoroalkyl substances with gestational diabetes mellitus and postpartum blood glucose. J Environ Sci (China). 2018;69:5–11. https://doi.org/10.1016/j.jes.2018.03.016. · DOI · Paper page
  46. Li J, Yao J, Xia W, Dai J, Liu H, Pan Y, et al. Association between exposure to per- and polyfluoroalkyl substances and blood glucose in pregnant women. Int J Hyg Environ Health. 2020;230:113596. https://doi.org/10.1016/j.ijheh.2020.113596. · DOI
  47. Valvi D, Oulhote Y, Weihe P, Dalgård C, Bjerve KS, Steuerwald U, et al. Gestational diabetes and offspring birth size at elevated environmental pollutant exposures. Environ Int. 2017;107:205–15. https://doi.org/10.1016/j.envint.2017.07.016. · DOI · Paper page
  48. Jensen RC, Glintborg D, Timmermann CAG, Nielsen F, Kyhl HB, Andersen HR, et al. Perfluoroalkyl substances and glycemic status in pregnant Danish women: the Odense child cohort. Environ Int. 2018;116:101–7. https://doi.org/10.1016/j.envint.2018.04.010. · DOI · Paper page
  49. Ren Y, Jin L, Yang F, Liang H, Zhang Z, Du J, et al. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women. Environ Health. 2020;19(1):88. https://doi.org/10.1186/s12940-020-00640-8. · DOI
  50. Mehta SS, James-Todd T, Applebaum KM, Bellavia A, Coleman-Phox K, Adler N, et al. Persistent organic pollutants and maternal glycemic outcomes in a diverse pregnancy cohort of overweight women. Environ Res. 2021;193:110551. https://doi.org/10.1016/j.envres.2020.110551. · DOI
  51. Cardenas A, Gold DR, Hauser R, Kleinman KP, Hivert MF, Calafat AM, et al. Plasma concentrations of per- and Polyfluoroalkyl substances at baseline and associations with glycemic indicators and Diabetes incidence among high-risk adults in the Diabetes prevention program trial. Environ Health Perspect. 2017;125(10):107001. https://doi.org/10.1289/EHP1612. · DOI · Paper page
  52. Kim MJ, Moon S, Oh BC, Jung D, Ji K, Choi K, et al. Association between perfluoroalkyl substances exposure and thyroid function in adults: a meta-analysis. Plos One. 2018;13(5):e0197244. https://doi.org/10.1371/journal.pone.0197244. · DOI · Paper page
  53. Aimuzi R, Luo K, Huang R, Huo X, Nian M, Ouyang F, et al. Perfluoroalkyl and polyfluroalkyl substances and maternal thyroid hormones in early pregnancy. Environ Pollut. 2020;264:114557. · DOI · Paper page
  54. Berg V, Nøst TH, Hansen S, Elverland A, Veyhe AS, Jorde R, et al. Assessing the relationship between perfluoroalkyl substances, thyroid hormones and binding proteins in pregnant women; a longitudinal mixed effects approach. Environ Int. 2015;77:63–9. https://doi.org/10.1016/j.envint.2015.01.007. · DOI · Paper page
  55. Chan E, Burstyn I, Cherry N, Bamforth F, Martin JW. Perfluorinated acids and hypothyroxinemia in pregnant women. Environ Res. 2011;111(4):559–64. https://doi.org/10.1016/j.envres.2011.01.011. · DOI
  56. Inoue K, Ritz B, Andersen SL, Ramlau-Hansen CH, Hoyer BB, Bech BH, et al. Perfluoroalkyl substances and maternal thyroid hormones in early pregnancy; findings in the Danish national birth cohort. Environ Health Perspect. 2019;127(11):117002. https://doi.org/10.1289/EHP5482. · DOI · Paper page
  57. Itoh S, Araki A, Miyashita C, Yamazaki K, Goudarzi H, Minatoya M, et al. Association between perfluoroalkyl substance exposure and thyroid hormone/thyroid antibody levels in maternal and cord blood: The Hokkaido Study. Environ Int. 2019;133(Pt A):105139. · DOI · Paper page
  58. Lebeaux RM, Doherty BT, Gallagher LG, Zoeller RT, Hoofnagle AN, Calafat AM, et al. Maternal serum perfluoroalkyl substance mixtures and thyroid hormone concentrations in maternal and cord sera: the HOME study. Environ Res. 2020;185:109395. https://doi.org/10.1016/j.envres.2020.109395. · DOI · Paper page
  59. Reardon AJF, Khodayari Moez E, Dinu I, Goruk S, Field CJ, Kinniburgh DW, et al. Longitudinal analysis reveals early-pregnancy associations between perfluoroalkyl sulfonates and thyroid hormone status in a Canadian prospective birth cohort. Environ Int. 2019;129:389–99. https://doi.org/10.1016/j.envint.2019.04.023. · DOI · Paper page
  60. Wang Y, Starling AP, Haug LS, Eggesbo M, Becher G, Thomsen C, et al. Association between perfluoroalkyl substances and thyroid stimulating hormone among pregnant women: a cross-sectional study. Environ Health. 2013;12(1):76. https://doi.org/10.1186/1476-069X-12-76. · DOI · Paper page
  61. Xiao C, Grandjean P, Valvi D, Nielsen F, Jensen TK, Weihe P, et al. Associations of exposure to Perfluoroalkyl substances with thyroid hormone concentrations and birth size. J Clin Endocrinol Metab. 2020;105(3):735–45. https://doi.org/10.1210/clinem/dgz147. · DOI · Paper page
  62. Yang L, Li J, Lai J, Luan H, Cai Z, Wang Y, et al. Placental transfer of Perfluoroalkyl substances and associations with thyroid hormones: Beijing prenatal exposure study. Sci Rep. 2016;6(1):21699. https://doi.org/10.1038/srep21699. · DOI · Paper page
  63. Berg V, Nøst TH, Pettersen RD, Hansen S, Veyhe AS, Jorde R, et al. Persistent organic pollutants and the association with maternal and infant thyroid homeostasis: a multipollutant assessment. Environ Health Perspect. 2017;125(1):127–33. https://doi.org/10.1289/EHP152. · DOI · Paper page
  64. Hernán MA, Robins JM. Causal inference: what if. Boca Raton: Chapman & Hall/CRC; 2020.
  65. Pearl J: Causality: models, reasoning, and inference. Boston: Cambridge University Press; 2000.
  66. Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol. 2008;8(1):70. https://doi.org/10.1186/1471-2288-8-70. · DOI · Paper page
  67. Naimi AI, Cole SR, Kennedy EH. An introduction to g methods. Int J Epidemiol. 2017;46(2):756–62. https://doi.org/10.1093/ije/dyw323. · DOI · Paper page
  68. Greenland S, Robins JM. Confounding and misclassification. Am J Epidemiol. 1985;122(3):495–506. https://doi.org/10.1093/oxfordjournals.aje.a114131. · DOI · Paper page
  69. Kim J, Lee G, Lee YM, Zoh KD, Choi K. Thyroid disrupting effects of perfluoroundecanoic acid and perfluorotridecanoic acid in zebrafish (Danio rerio) and rat pituitary (GH3) cell line. Chemosphere. 2021;262:128012. https://doi.org/10.1016/j.chemosphere.2020.128012. · DOI
  70. Wang J, Shi G, Yao J, Sheng N, Cui R, Su Z, et al. Perfluoropolyether carboxylic acids (novel alternatives to PFOA) impair zebrafish posterior swim bladder development via thyroid hormone disruption. Environ Int. 2020;134:105317. https://doi.org/10.1016/j.envint.2019.105317. · DOI · Paper page
  71. Weiss JM, Andersson PL, Lamoree MH, Leonards PE, van Leeuwen SP, Hamers T. Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol Sci. 2009;109(2):206–16. https://doi.org/10.1093/toxsci/kfp055. · DOI · Paper page
  72. Yu WG, Liu W, Jin YH. Effects of perfluorooctane sulfonate on rat thyroid hormone biosynthesis and metabolism. Environ Toxicol Chem. 2009;28(5):990–6. https://doi.org/10.1897/08-345.1. · DOI · Paper page
  73. Williams FL, Watson J, Ogston SA, Visser TJ, Hume R, Willatts P. Maternal and umbilical cord levels of T4, FT4, TSH, TPOAb, and TgAb in term infants and neurodevelopmental outcome at 5.5 years. J Clin Endocrinol Metab. 2013;98(2):829–38. https://doi.org/10.1210/jc.2012-3572. · DOI · Paper page
  74. Jiang Q, Gao H, Zhang L. Metabolic Effects PFAS. In: JC DW, editor. Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances. Cham: Springer International Publishing; 2015. p. 177–201. · DOI
  75. Hagenaars A, Knapen D, Meyer IJ, van der Ven K, Hoff P, De Coen W. Toxicity evaluation of perfluorooctane sulfonate (PFOS) in the liver of common carp (Cyprinus carpio). Aquat Toxicol. 2008;88(3):155–63. · DOI
  76. Blake BE, Cope HA, Hall SM, Keys RD, Mahler BW, McCord J, et al. Evaluation of maternal, embryo, and placental effects in CD-1 mice following gestational exposure to Perfluorooctanoic acid (PFOA) or Hexafluoropropylene oxide dimer acid (HFPO-DA or GenX). Environ Health Perspect. 2020;128(2):27006. https://doi.org/10.1289/EHP6233. · DOI · Paper page
  77. Sant KE, Jacobs HM, Borofski KA, Moss JB, Timme-Laragy AR. Embryonic exposures to perfluorooctanesulfonic acid (PFOS) disrupt pancreatic organogenesis in the zebrafish, Danio rerio. Environ Pollut. 2017;220(Pt B):807–17. · DOI · Paper page
  78. Ojo AF, Peng C, Ng JC. Combined effects and toxicological interactions of perfluoroalkyl and polyfluoroalkyl substances mixtures in human liver cells (HepG2). Environ Pollut. 2020;263(Pt B):114182. · DOI · Paper page
  79. Bobb JF, Valeri L, Claus Henn B, Christiani DC, Wright RO, Mazumdar M, et al. Bayesian kernel machine regression for estimating the health effects of multi-pollutant mixtures. Biostatistics. 2015;16(3):493–508. · DOI · Paper page
  80. Eryasa B, Grandjean P, Nielsen F, Valvi D, Zmirou-Navier D, Sunderland E, et al. Physico-chemical properties and gestational diabetes predict transplacental transfer and partitioning of perfluoroalkyl substances. Environ Int. 2019;130:104874. https://doi.org/10.1016/j.envint.2019.05.068. · DOI · Paper page
  81. Li X, Ye L, Ge Y, Yuan K, Zhang Y, Liang Y, et al. In utero perfluorooctane sulfonate exposure causes low body weights of fetal rats: a mechanism study. Placenta. 2016;39:125–33. https://doi.org/10.1016/j.placenta.2016.01.010. · DOI
  82. Suh CH, Cho NK, Lee CK, Lee CH, Kim DH, Kim JH, et al. Perfluorooctanoic acid-induced inhibition of placental prolactin-family hormone and fetal growth retardation in mice. Mol Cell Endocrinol. 2011;337(1–2):7–15. https://doi.org/10.1016/j.mce.2011.01.009. · DOI
  83. Leemans M, Couderq S, Demeneix B, Fini JB. Pesticides with potential thyroid hormone-disrupting effects: a review of recent data. Front Endocrinol (Lausanne). 2019;10:743. https://doi.org/10.3389/fendo.2019.00743. · DOI · Paper page
  84. Takser L, Mergler D, Baldwin M, de Grosbois S, Smargiassi A, Lafond J. Thyroid hormones in pregnancy in relation to environmental exposure to organochlorine compounds and mercury. Environ Health Perspect. 2005;113(8):1039–45. https://doi.org/10.1289/ehp.7685. · DOI · Paper page
  85. Luo D, Pu Y, Tian H, Wu W, Sun X, Zhou T, et al. Association of in utero exposure to organochlorine pesticides with thyroid hormone levels in cord blood of newborns. Environ Pollut. 2017;231(Pt 1):78–86. · DOI
  86. Saldana TM, Basso O, Hoppin JA, Baird DD, Knott C, Blair A, et al. Pesticide exposure and self-reported gestational diabetes mellitus in the agricultural health study. Diabetes Care. 2007;30(3):529–34. https://doi.org/10.2337/dc06-1832. · DOI · Paper page
  87. Eslami B, Naddafi K, Rastkari N, Rashidi BH, Djazayeri A, Malekafzali H. Association between serum concentrations of persistent organic pollutants and gestational diabetes mellitus in primiparous women. Environ Res. 2016;151:706–12. · DOI
  88. Bedi M, von Goetz N, Ng C. Estimating polybrominated diphenyl ether (PBDE) exposure through seafood consumption in Switzerland using international food trade data. Environ Int. 2020;138:105652. https://doi.org/10.1016/j.envint.2020.105652. · doi:10.1016/j.envint.2020.105652
  89. Darnerud PO, Eriksen GS, Jóhannesson T, Larsen PB, Viluksela M. Polybrominated diphenyl ethers: occurrence, dietary exposure, and toxicology. Environ Health Perspect. 2001;109(Suppl 1):49–68. · DOI · Paper page
  90. Herbstman JB, Sjödin A, Kurzon M, Lederman SA, Jones RS, Rauh V, et al. Prenatal exposure to PBDEs and neurodevelopment. Environ Health Perspect. 2010;118(5):712–9. https://doi.org/10.1289/ehp.0901340. · DOI · Paper page
  91. Molehin D, Dekker Nitert M, Richard K. Prenatal exposures to multiple thyroid hormone disruptors: effects on glucose and lipid metabolism. J Thyroid Res. 2016;2016:8765049. · DOI
  92. Shaffer RM, Ferguson KK, Sheppard L, James-Todd T, Butts S, Chandrasekaran S, et al. Maternal urinary phthalate metabolites in relation to gestational diabetes and glucose intolerance during pregnancy. Environ Int. 2019;123:588–96. https://doi.org/10.1016/j.envint.2018.12.021. · DOI · Paper page
  93. Adibi JJ, Lee MK, Naimi AI, Barrett E, Nguyen RH, Sathyanarayana S, et al. Human chorionic gonadotropin partially mediates phthalate association with male and female Anogenital distance. J Clin Endocrinol Metab. 2015;100(9):E1216–24. https://doi.org/10.1210/jc.2015-2370. · DOI · Paper page
  94. Adibi JJ, Zhao Y, Zhan LV, Kapidzic M, Larocque N, Koistinen H, et al. An investigation of the single and combined phthalate metabolite effects on human chorionic gonadotropin expression in placental cells. Environ Health Perspect. 2017;125(10):107010. https://doi.org/10.1289/EHP1539. · DOI

Cited by

See all 70

Metadata

Authors
Birru, R. L., Liang, H.-W., Farooq, F., Bedi, M., Feghali, M., Haggerty, C. L., Mendez, D. D., Catov, J. M., Ng, C. A., & Adibi, J. J.
Venue
Environmental Health
Published
2021-05-22
Volume
20
Issue
1
Pages
63-63
ISSN
1476-069X (ISSN-L)
OpenAlex
W3165847000
Cited by
70
References
35
FWCI
3.88
Type
journal article
Language
en
Open access
gold
Licence
Funders
National Institutes of Health (5R01ES029336-02, 1R56AI139189-01)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus. https://app.cochat.ai/papers/10.1186/s12940-021-00740-z
The paper
Birru, R. L., Liang, H.-W., Farooq, F., Bedi, M., Feghali, M., Haggerty, C. L., Mendez, D. D., Catov, J. M., Ng, C. A., & Adibi, J. J. (2021). A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus. Environmental Health. https://doi.org/10.1186/s12940-021-00740-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.